ELAMF yields 71.43% · JNJ yields 2.13%● Live data
📍 ELAMF pulled ahead of the other in Year 1
Combined, ELAMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ELAMF + JNJ for your $10,000?
Elamex SA de CV engages in candy manufacturing, and nut processing and packaging in the United States and Mexico. It produces sugar candies, such as starlight mints, orange slices, spice drops, jelly beans, and gummies. The company also processes packaged nuts, including pecans, walnuts, and almonds; and bulk foodservice items, such as sunflower seeds and trail mixes. In addition, it offers contract manufacturing services for food products; and warehousing and logistics services. Further, the company engages in real estate holdings in Mexico. It sells sugar candies through grocery, drug, mass merchant, food service, and convenience channels; and markets and distributes packaged nuts to foodservice and retail markets. The company serves restaurants, healthcare facilities, hotels, schools, and colleges. Elamex SA de CV was founded in 1973 and is headquartered in El Paso, Texas. It has operations in Mexico and the United States. The company has a distribution center in El Paso, Texas.
Full ELAMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.